Pulse Biosciences, Inc. (PLSE) – Hot FDA News
-
Pulse Biosciences (PLSE) Announces Positive Clinical Data on Nano-Pulse Stimulation Procedure for Low-Risk Basal Cell Carcinoma Lesions
-
Pulse Biosciences (PLSE) Receives Not Substantially Equivalent Letter from FDA on CellFX System
-
Back to PLSE Stock Lookup